
Fifty-one cancer pain patients with limited zzso exposure participated in a randomized, zzso zzso zzso comparison of two dosage strengths of the zzso zzso preparation, zzso zzso zzso (The Purdue Frederick Company, Norwalk, zzso The patients were first stabilized on zzso oral zzso 30 zzso every 4 hours, with 15 zzso available every 2 hours as needed for breakthrough pain zzso zzso Each patient then received either one 100 zzso zzso zzso tablet or three zzso zzso zzso zzso every 12 hours, with rescue medication as needed, for 3 zzso Analysis of study power revealed sufficient sensitivity to detect clinically relevant differences in pain intensity and use of rescue zzso The two tablet strengths yielded similar pain relief, use of rescue medication, and frequency of side zzso In addition, pain and use of rescue medication did not change from the beginning to the end of the 12-hour dosing intervals in either zzso In the study population as a whole, pain intensity was lower and total zzso intake higher during the period on zzso zzso These data establish comparable zzso efficacy and side effect potential of these two dosage strengths and confirm a 12-hour duration of effect for zzso The improved analgesia on the zzso zzso may be attributable to increased consumption of drug resulting from improved zzso 

